Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis

BACKGROUND: Anthracyclines are commonly used chemotherapeutic agents to treat malignant tumors. However, cardiotoxicity is a potentially serious adverse effect of anthracyclines. Beta-blockers may be effective in preventing anthracycline-induced cardiotoxicity (AIC). However, the lack of direct comp...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Dongsheng, Hu, Jun, Li, Ying, Zeng, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403514/
https://www.ncbi.nlm.nih.gov/pubmed/36035937
http://dx.doi.org/10.3389/fcvm.2022.968534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403514/
https://www.ncbi.nlm.nih.gov/pubmed/36035937
http://dx.doi.org/10.3389/fcvm.2022.968534

Ejemplares similares